Correlation Between Iovance Biotherapeutics and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Cullinan Oncology LLC, you can compare the effects of market volatilities on Iovance Biotherapeutics and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Cullinan Oncology.
Diversification Opportunities for Iovance Biotherapeutics and Cullinan Oncology
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Iovance and Cullinan is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Cullinan Oncology
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to under-perform the Cullinan Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Iovance Biotherapeutics is 1.1 times less risky than Cullinan Oncology. The stock trades about -0.26 of its potential returns per unit of risk. The Cullinan Oncology LLC is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 1,306 in Cullinan Oncology LLC on October 7, 2024 and sell it today you would lose (38.00) from holding Cullinan Oncology LLC or give up 2.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Cullinan Oncology LLC |
Iovance Biotherapeutics and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Cullinan Oncology
The main advantage of trading using opposite Iovance Biotherapeutics and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |